A public health and budget impact analysis of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK

被引:10
作者
Jiang, Yiling [1 ]
Gauthier, Aline [1 ]
Keeping, Sam [2 ]
Carroll, Stuart [2 ]
机构
[1] Amaris, London N7 9AS, England
[2] Sanofi Pasteur MSD, Maidenhead SL6 1QP, Berks, England
关键词
budget impact analysis; epidemiological change; invasive pneumococcal diseases; pneumococcal conjugate vaccine; pneumococcal polysaccharide vaccine; public health; COST-EFFECTIVENESS ANALYSIS; WESTERN-EUROPEAN COUNTRIES; HERD-IMMUNITY; OLDER-ADULTS; DISEASE; PNEUMONIA; ENGLAND; PREVENTION; STRATEGIES; INFLUENZA;
D O I
10.1586/14737167.2014.953932
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Since the introduction of the routine childhood immunization, a change in epidemiology of pneumococcal disease has been seen in both children and adults. This study aimed to quantify the public health and budget impact of pneumococcal vaccination of the elderly and those in at risk groups in the UK. Methods: The model was adapted from a previous population-based Markov model. At-risk adults and the elderly were assumed to receive PPV23 or PCV13 vaccination or no vaccination. Results: Over the study period (2012-2016), PPV23 vaccination led to a reduction in the number of invasive pneumococcal disease cases in most scenarios. The net budget impact ranged between 15 pound and 39 pound million (vs no vaccination) or between -116 pound and -93 pound million (vs PCV13). Conclusion: PPV23 vaccination program remains the optimal strategy from public health and budgetary perspectives despite epidemiological changes. PCV13 is likely to impose a significant budget with limited health benefits.
引用
收藏
页码:901 / 911
页数:11
相关论文
共 50 条
[31]   Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®] [J].
Sean T. Duggan .
Drugs, 2010, 70 :1973-1986
[32]   13-valent pneumococcal conjugate vaccine in Africa [J].
Cohen, Robert ;
Levy, Corinne .
LANCET GLOBAL HEALTH, 2017, 5 (03) :E244-E245
[33]   Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children [J].
Esposito, Susanna ;
Principi, Nicola .
JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
[34]   Compared effectiveness of the 7-valent pneumococcal conjugate vaccine in children with the 13-valent vaccine in adults [J].
Gaillat, J. .
MEDECINE ET MALADIES INFECTIEUSES, 2013, 43 (06) :215-221
[35]   Pneumococcal Nasopharyngeal Carriage following Reduced Doses of a 7-Valent Pneumococcal Conjugate Vaccine and a 23-Valent Pneumococcal Polysaccharide Vaccine Booster [J].
Russell, F. M. ;
Carapetis, J. R. ;
Satzke, C. ;
Tikoduadua, L. ;
Waqatakirewa, L. ;
Chandra, R. ;
Seduadua, A. ;
Oftadeh, S. ;
Cheung, Y. B. ;
Gilbert, G. L. ;
Mulholland, E. K. .
CLINICAL AND VACCINE IMMUNOLOGY, 2010, 17 (12) :1970-1976
[36]   Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England [J].
Mugwagwa, Tendai ;
Averin, Ahuva ;
Atwood, Mark ;
Sato, Reiko ;
Vyse, Andrew ;
Campling, James ;
Weycker, Derek ;
Slack, Mary ;
Ellsbury, Gillian ;
Mendes, Diana .
EXPERT REVIEW OF VACCINES, 2022, 21 (09) :1331-1341
[37]   Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage Among American Indians [J].
Grant, Lindsay R. ;
Hammitt, Laura L. ;
O'Brien, Sarah E. ;
Jacobs, Michael R. ;
Donaldson, Connie ;
Weatherholtz, Robert C. ;
Reid, Raymond ;
Santosham, Mathuram ;
O'Brien, Katherine L. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (08) :907-914
[38]   Cost-effectiveness of the 13-valent Pneumococcal Conjugate Vaccine in Children in Portugal [J].
Gouveia, Miguel ;
Fiorentino, Francesca ;
Jesus, Goncalo ;
Costa, Joao ;
Borges, Margarida .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (08) :782-787
[39]   Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in 23-valent pneumococcal polysaccharide vaccine-naive and previously immunized adult patients with severe chronic kidney disease [J].
Ulanova, Marina ;
Huska, Brenda ;
Desbiens, Angele ;
Gaultier, Gabrielle N. ;
Domonkos, Victoria ;
McCready, William G. .
VACCINE, 2021, 39 (04) :699-710
[40]   Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children [J].
Olarte, Liset ;
Barson, William J. ;
Barson, Ryan M. ;
Lin, Philana Ling ;
Romero, Jose R. ;
Tan, Tina Q. ;
Givner, Laurence B. ;
Bradley, John S. ;
Hoffman, Jill A. ;
Hulten, Kristina G. ;
Mason, Edward O. ;
Kaplan, Sheldon L. .
CLINICAL INFECTIOUS DISEASES, 2015, 61 (05) :767-775